Efficacy of Combined MEK and CDK Targeted Therapies for Pancreatic Neuroendocrine Tumors

Abstract

Open access

Peer reviewed

S Umesalma, C A Kaemmer, C K Maharjan, J L Kohlmeyer, D Goldfard, E Wilkerson, R M Sheehy, M R Sheehy, M R Leidinger, D K Meyerholz, …

PANCREAS, Vol.50(3), pp.444-444

2021

DOI: 10.1097/MPA.0000000000001763

Files and links (1)

url

https://doi.org/10.1097/MPA.0000000000001763View

Published (Version of record) Open Access

Title: Subtitle: Efficacy of Combined MEK and CDK Targeted Therapies for Pancreatic Neuroendocrine Tumors
Creators: S Umesalma
C A Kaemmer
C K Maharjan
J L Kohlmeyer
D Goldfard
E Wilkerson
R M Sheehy
M R Sheehy
M R Leidinger
D K Meyerholz
S Bell
G Zamba
T M O'Dorisio
J Dillion
A Scott
P H Ear
T A Braun
J R Howe
C Chandrasekharan
A M Bellizzi
L Herring
L M Graves
B W Darbro
D E Quelle
Resource Type: Abstract
Publication Details: PANCREAS, Vol.50(3), pp.444-444
DOI: 10.1097/MPA.0000000000001763
ISSN: 1536-4828
Language: English
Date published: 2021
Academic Unit: Radiology; Biostatistics; Surgery; Hematology, Oncology, and Blood & Marrow Transplantation; Stead Family Department of Pediatrics; Endocrinology and Metabolism; Internal Medicine; Pathology; Neuroscience and Pharmacology; Roy J. Carver Department of Biomedical Engineering; Medical Genetics and Genomics
Record Identifier: 9984239451902771

19 Record Views